FDA Inspection 1169069 — Sunny Pharmtech Inc.

Sunny Pharmtech Inc. — FEI 3013166187

The FDA completed an inspection of Sunny Pharmtech Inc. on April 15, 2022 in Taoyuan City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Taoyuan City (Taiwan)